IBB’s small-cap stocks outperformed
Going by market cap, the top ten small-cap stocks of the iShares Nasdaq Biotechnology ETF (IBB) outperformed the IBB and the SPDR S&P 500 ETF (SPY) with an average return of 6.3%. IBB gave a return of 4.4% and SPY returned 1.5% on October 15, 2015.
IBB’s top ten small-cap stocks outperformed its overall top ten stocks and its top ten mid-cap stocks. The combined weight of IBB’s top ten small-cap stocks stood at 2.8% of its portfolio.
The above graph reflects the performance of IBB’s top ten small-cap stocks with IBB and SPY on October 15, 2015.
Ironwood Pharmaceuticals rose 5.7%
Ironwood Pharmaceuticals (IRWD) rose by 5.7% on October 15, 2015. In the trailing-five-day period, the stock has given an average return of 3.1%. On October 13, 2015, IRWD announced, “that the Phase III clinical trial of its 72 mcg dose of linaclotide in adults with chronic idiopathic constipation (or CIC) met the primary endpoint. Ironwood and partner Allergan plc intend to submit a supplemental new drug application to the U.S. Food and Drug Administration (or FDA) in the first half of 2016.”
IRWD closed at $11.46 and was trading above its 20-day and 50-day moving averages, but below its 100-day moving average. IRWD has a weight of 0.25% in IBB’s portfolio.